- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05385653
Pre-therapeutic Validation of the Virtual Reality-based Exposure Scenario for CBT "ReVBED" for the Induction of Food Craving in Patients With Bulimia and Binge Eating Disorder (BED) (RevBED)
Pre-therapeutic Validation of the VR-based Exposure Scenario for CBT "ReVBEB" for the Induction of Food Craving in Patients With Bulimia and Binge Eating Disorder
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Eating Disorders-specialized clinicians from Saint-Etienne University Hospital Center (CHU) and VR-specialized engineers from National School of Engineering of Saint-Etienne (ENISE) therefore collaborated in the creation of ReVBED, a VR-based exposure scenario for CBT for the induction of food craving in eating disorders with binge eating. ReVBED offers successive exposures to multimodal stimuli in a coherent scenario and in an immersive virtual environment via a wireless VR headset.
Our first objective is to validate the effectiveness of our scenario in inducing food craving in patients with bulimia and BED.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Aurélia GAY, MD
- Phone Number: +33 (0)477127750
- Email: aurelia.gay@chu-st-etienne.fr
Study Contact Backup
- Name: Hélène RAINGARD, CRA
- Phone Number: +33 (0)477829703
- Email: helene.raingard@chu-st-etienne.fr
Study Locations
-
-
-
Saint-Etienne, France
- Recruiting
- CHU Saint-Etienne
-
Sub-Investigator:
- Baptiste RAVEY, MD
-
Principal Investigator:
- Aurélia GAY, MD
-
Sub-Investigator:
- Catherine MASSOUBRE, MD PhD
-
Sub-Investigator:
- Vikesh BHOOWABUL, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients: who meet Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 criteria for Bulimia Nervosa or Binge Eating Disorder
- Controls: paired to patients on age and level of education
Exclusion Criteria:
- Patients and controls:
- Under legal protection measure (guardianship, curatorship or safeguard of justice)
- Having a treatment being established and / or not stabilized (declarative) able to alter the physiological data recorded and the answers to the self-questionnaires
- Having one or more sensory deficit(s) or disorder(s) incompatible with the use of VR equipment (declarative)
- Patients: who have already benefited from specific care targeting food craving (declarative) Controls: with a score greater than or equal to 88 on the Bulimia Test (BULIT)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: patients with bulimia or binge eating disorder
|
ReVBED is a VR-based exposure scenario for CBT for the induction of food craving in patients with bulimia nervosa and binge eating disorder. The use of ReVBED requires no VR experience and only generic and commonly used virtual reality tools (a computer with VR software, a wireless virtual reality headset, two controllers and headphones), all with a CE mark, allowing its users to move in and interact with a specially designed virtual environment. This exhibit scenario takes place in a VR environment built to represent a standard apartment consisting of four exhibit rooms (a bedroom, a teenager's bedroom, a living room and a kitchen) in which the ReVBED user moves sequentially through the scenario. In each room, specific cues of craving are displayed. These cues are not only visual, but also audio, emotional and socio-environmental. A central hall connects the other rooms and serves as a safe place for debriefing, where measures such as craving are assessed.
Other Names:
|
Other: control
paired healthy controls
|
ReVBED is a VR-based exposure scenario for CBT for the induction of food craving in patients with bulimia nervosa and binge eating disorder. The use of ReVBED requires no VR experience and only generic and commonly used virtual reality tools (a computer with VR software, a wireless virtual reality headset, two controllers and headphones), all with a CE mark, allowing its users to move in and interact with a specially designed virtual environment. This exhibit scenario takes place in a VR environment built to represent a standard apartment consisting of four exhibit rooms (a bedroom, a teenager's bedroom, a living room and a kitchen) in which the ReVBED user moves sequentially through the scenario. In each room, specific cues of craving are displayed. These cues are not only visual, but also audio, emotional and socio-environmental. A central hall connects the other rooms and serves as a safe place for debriefing, where measures such as craving are assessed.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Verbal Rating Scales of food craving (VRS)
Time Frame: Change from the first exploration of virtual rooms to the last exploration (20 minutes)
|
Evaluate variation in food craving assessed by Verbal Rating Scales (VRS) : self-assessment from 0 to 10 with 0 = "no food craving felt" and 10 = "maximum food craving felt")
|
Change from the first exploration of virtual rooms to the last exploration (20 minutes)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Verbal Rating Scales of food craving (VRS)
Time Frame: Change from the start of exploration of each virtual rooms to the end (5 minutes)
|
Evaluate variation in food craving assessed by Verbal Rating Scales (VRS : self-assessment from 0 to 10 with 0 = "no food craving felt" and 10 = "maximum food craving felt")
|
Change from the start of exploration of each virtual rooms to the end (5 minutes)
|
Heart rate variation
Time Frame: Change from the first exploration of virtual rooms to the last exploration (20 minutes)
|
Measurement of cyclical fluctuations with sensor
|
Change from the first exploration of virtual rooms to the last exploration (20 minutes)
|
Pupillometry
Time Frame: Change from the first exploration of virtual rooms to the last exploration (20 min)
|
Measurement of phase fluctuations of pupil diameters with visual sensor
|
Change from the first exploration of virtual rooms to the last exploration (20 min)
|
Electro-Dermal Activity
Time Frame: Change from the first exploration of virtual rooms to the last exploration (20 minutes)
|
Measurement of skin conductance fluctuations by amplifying the potential differences between two electrodes in contact with the subject's skin
|
Change from the first exploration of virtual rooms to the last exploration (20 minutes)
|
Heart rate variation
Time Frame: Change from the start of exploration of each virtual rooms to the end (5 minutes)
|
Measurement of cyclical fluctuations with sensor
|
Change from the start of exploration of each virtual rooms to the end (5 minutes)
|
Pupillometry
Time Frame: Change from the start of exploration of each virtual rooms to the end (5 minutes)
|
Measurement of phase fluctuations of pupil diameters with visual sensor
|
Change from the start of exploration of each virtual rooms to the end (5 minutes)
|
Electro-Dermal Activity
Time Frame: Change from the start of exploration of each virtual rooms to the end (5 minutes)
|
Measurement of skin conductance fluctuations by amplifying the potential differences between two electrodes in contact with the subject's skin
|
Change from the start of exploration of each virtual rooms to the end (5 minutes)
|
Variations of the measurements VRS of the food craving and each of the physiological measurements of the food craving
Time Frame: Change from the start of exploration of each virtual rooms to the end (5 minutes)
|
Correlation between the variations of the VRS measurements and each of the physiological measurements (HRV, pupillometry and EDA) of the food craving induced in patients with bulimia and BED, compared to matched healthy controls.
|
Change from the start of exploration of each virtual rooms to the end (5 minutes)
|
Verbal Rating Scales of anxiety (VRS)
Time Frame: Change from the first exploration of virtual rooms to the last exploration (20 minutes)
|
Evaluate variation of anxiety assessed by Verbal Rating Scales (VRS : self-assessment from 0 to 10 with 0 = "no food craving felt" and 10 = "maximum food craving felt")
|
Change from the first exploration of virtual rooms to the last exploration (20 minutes)
|
Verbal Rating Scales of anxiety (VRS)
Time Frame: Change from the start of exploration of each virtual rooms to the end (5 minutes)
|
Evaluate variation of anxiety assessed by Verbal Rating Scales (VRS) : self-assessment from 0 to 10 with 0 = "no food craving felt" and 10 = "maximum food craving felt")
|
Change from the start of exploration of each virtual rooms to the end (5 minutes)
|
Variations of the VRS food craving and of the VRS anxiety of the food craving
Time Frame: Change from the start of exploration of each virtual rooms to the end (5 minutes)
|
Correlation between the variations Food Craving Verbal Rating Scales and Anxiety Verbal Rating Scales (VRS : self-assessment from 0 to 10 with 0 = "no felt" and 10 = "maximum felt") the VRS food craving and VRS anxiety
|
Change from the start of exploration of each virtual rooms to the end (5 minutes)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Aurélia GAY, MD, CHU DE SAINT-ETIENNE
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 21CH086
- ANSM (Other Identifier: 2024-A00286-41)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Binge-Eating Disorder
-
University of North Carolina, Chapel HillThe Hilda & Preston Davis Foundation; Global Foundation for Eating DisordersCompletedEating Disorder | Binge-eating DisorderUnited States
-
ShireCompleted
-
Lindner Center of HOPEUniversity of CincinnatiCompleted
-
Sao Jose do Rio Preto Medical SchoolFundação de Amparo à Pesquisa do Estado de São PauloCompletedBinge-Eating Disorder | Eating Disorders | Eating Behavior | Eating Disorder | Binge Eating Disorder Associated With ObesityBrazil
-
Nova Scotia Health AuthorityCompletedBinge-Eating Disorder | Eating DisorderCanada
-
BioprojetRecruiting
-
Lindner Center of HOPEJazz PharmaceuticalsRecruiting
-
Idorsia Pharmaceuticals Ltd.Completed
-
University of ChicagoTakedaCompleted
Clinical Trials on experimentation of the virtual reality "RevBED"
-
Assistance Publique Hopitaux De MarseilleUnknown
-
Augmented eXperience E-health LaboratoryActive, not recruiting
-
Taipei Medical UniversityNot yet recruitingDementia | Caregiver Burden
-
Karabuk UniversityCompletedFractures, Bone | Pain, Acute | Anxiety AcuteTurkey
-
University of ArkansasRecruitingEndocervical CancerUnited States
-
Central Institute of Mental Health, MannheimGerman Research FoundationWithdrawnLoneliness | Life Change EventsGermany
-
University of SevilleInstituto para el Estudio de la Biología de la Reproducción HumanaRecruitingPassive-Aggressive Personality DisorderSpain
-
Alexandria UniversityNot yet recruiting
-
University Hospital, BrestRecruiting
-
Umm Al-Qura UniversityRecruiting